Search research articles
Contact Us
Filters
Showing results (161-170 of 331) with videos related to
Page
of 34
Sort By:
Pharmacoeconomics
|
December 18, 2009
Adverse drug interactions: moving from perception to action
Ryan Mayhew, June M McKoy, Thanh Ha Luu, et al.
Archives of Internal Medicine
|
September 15, 2010
Association between pharmaceutical support and basic science research on erythropoiesis-stimulating agents
Charles L Bennett, Stephen Y Lai, Michael Henke, et al.
Community Oncology
|
January 5, 2010
Sildenafil- and tadalafil-associated optic neuropathy: implications for men after prostate cancer treatment
June M McKoy, Carlos R Bolden, Athena Samaras, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 26, 2017
Effects of the US Food and Drug Administration Boxed Warning of Erythropoietin-Stimulating Agents on Utilization and Adverse Outcome
John Bian, Brian Chen, Dawn L Hershman, et al.
The Journal of Community and Supportive Oncology
|
February 27, 2016
Joint breast and colorectal cancer screenings in medically underserved women
Terry C Davis, Connie L Arnold, Michael S Wolf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2003
Perspectives on the value of American Society of Clinical Oncology clinical guidelines as reported by oncologists and health maintenance organizations
Charles L Bennett, Mark R Somerfield, David G Pfister, et al.
Archives of Internal Medicine
|
March 26, 2008
Treatment success in cancer: new cancer treatment successes identified in phase 3 randomized controlled trials conducted by the National Cancer Institute-sponsored cooperative oncology groups, 1955 to 2006
Benjamin Djulbegovic, Ambuj Kumar, Heloisa P Soares, et al.
Journal of Women'S Health (2002)
|
February 19, 2015
Sustaining mammography screening among the medically underserved: a follow-up evaluation
Terry C Davis, Connie L Arnold, Charles L Bennett, et al.
Medicina (Kaunas, Lithuania)
|
December 24, 2021
A New Criterion for Fluoroquinolone-Associated Disability Diagnosis: Functional Gastrointestinal Disorders
Deanna N Cannizzaro, Lydia F Naughton, Maya Z Freeman, et al.
The Lancet. Oncology
|
February 19, 2017
Generic drugs in oncology - Authors' reply
Charles L Bennett, Sumimasa Nagai, Y Tony Yang, et al.
Page
of 34
Search research articles
Search
Showing results (161-170 of 331) with videos related to
Sort By:
Page
of 34
Pharmacoeconomics
|
December 18, 2009
Adverse drug interactions: moving from perception to action
Ryan Mayhew, June M McKoy, Thanh Ha Luu, et al.
Archives of Internal Medicine
|
September 15, 2010
Association between pharmaceutical support and basic science research on erythropoiesis-stimulating agents
Charles L Bennett, Stephen Y Lai, Michael Henke, et al.
Community Oncology
|
January 5, 2010
Sildenafil- and tadalafil-associated optic neuropathy: implications for men after prostate cancer treatment
June M McKoy, Carlos R Bolden, Athena Samaras, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 26, 2017
Effects of the US Food and Drug Administration Boxed Warning of Erythropoietin-Stimulating Agents on Utilization and Adverse Outcome
John Bian, Brian Chen, Dawn L Hershman, et al.
The Journal of Community and Supportive Oncology
|
February 27, 2016
Joint breast and colorectal cancer screenings in medically underserved women
Terry C Davis, Connie L Arnold, Michael S Wolf, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2003
Perspectives on the value of American Society of Clinical Oncology clinical guidelines as reported by oncologists and health maintenance organizations
Charles L Bennett, Mark R Somerfield, David G Pfister, et al.
Archives of Internal Medicine
|
March 26, 2008
Treatment success in cancer: new cancer treatment successes identified in phase 3 randomized controlled trials conducted by the National Cancer Institute-sponsored cooperative oncology groups, 1955 to 2006
Benjamin Djulbegovic, Ambuj Kumar, Heloisa P Soares, et al.
Journal of Women'S Health (2002)
|
February 19, 2015
Sustaining mammography screening among the medically underserved: a follow-up evaluation
Terry C Davis, Connie L Arnold, Charles L Bennett, et al.
Medicina (Kaunas, Lithuania)
|
December 24, 2021
A New Criterion for Fluoroquinolone-Associated Disability Diagnosis: Functional Gastrointestinal Disorders
Deanna N Cannizzaro, Lydia F Naughton, Maya Z Freeman, et al.
The Lancet. Oncology
|
February 19, 2017
Generic drugs in oncology - Authors' reply
Charles L Bennett, Sumimasa Nagai, Y Tony Yang, et al.
Page
of 34